Incanthera ltd
WebIncanthera Ltd. develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific WebThe Company is a specialist oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It seeks to identify and develop innovative solutions to current clinical, commercially relevant unmet needs, utilising new technology from leading academic institutions.The Company’s current lead product and …
Incanthera ltd
Did you know?
WebIncanthera PLC is a UK-based, dermatology and oncology therapeutics company focusing on drug discovery and development of targeted medicines for the treatment of cancer. In … WebJun 21, 2016 · Incanthera Ltd. (Incanthera) is a biopharmaceutical company which discovers and develops pharmaceutical products for the treatment of cancer. Its drug candidates under development include ICT2588, a vascular disrupting agent, based on the tumor-blasting technology; and ICT03-Es5, a targeted bioreductive agent; which are …
WebIncanthera PLC is a UK-based, dermatology and oncology therapeutics company focusing on drug discovery and development of targeted medicines for the treatment of cancer. Deep … WebDeveloped by Prof Robert Falconer, Prof Paul Loadman and jointly funded by Cancer Research UK and Yorkshire Cancer Research the technology formed the basis for the launch of Incanthera Ltd (now plc), an ICT/University of Bradford spin-out company and now licenced to Ellipses Pharma.
WebFeb 28, 2024 · Incanthera Plc. The Company is a specialist oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. … WebPhone Number 441513315220. Incanthera Ltd. develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific matrix …
WebIncanthera debuts...Newco Incanthera Ltd. (Merseyside, U.K.) raised L375,000 ($574,000) in a seed round led by the North West Fund for Biomedical... Read More. BioCentury Jan 9, 2012. Financial News. Ai2 completes venture financing
WebIncanthera PLC is a UK-based, dermatology and oncology therapeutics company focusing on drug discovery and development of targeted medicines for the treatment of cancer. Deep dive We explore the... green cscs card trainingWebMore for INCANTHERA PLC (11026926) Registered office address 76 King Street, Manchester, England, M2 4NH . Company status Active Company type Public limited Company Incorporated on 23 October 2024. Accounts. Next accounts made up to 31 March 2024 due by 30 September 2024 ... green cscs card renewalWebIncanthera Ltd (Incanthera) is a biopharmaceutical company that discovers and develops therapeutic products for the treatment of cancer. The companys drug candidates under development include ICT2588, a vascular disrupting agent, based on the tumor-blasting technology; and ICT03 Es5, a targeted bioreductive agent; which are targeted at ... green crystal with brown spotsWebIn pursuit of best-in-class small molecule drugs to treat cancer and immunologic diseases floydtechWebHeadquarters. MANCHESTER. Locations. 76 KING STREET. MANCHESTER, GB. Get directions. Employees at INCANTHERA LIMITED. Suzanne Brocks. Head of … green crystal with black stripesWebFeb 28, 2024 · Incanthera Ltd., a spin-off from the University of Bradford Institute of Cancer Therapeutics, is developing ICT01 2588 for the treatment of lung, breast, ICT01 2588 - … floyd taylor motors hartlepoolWebThe ICT has already successfully used this technology to improve the therapeutic index of a colchicine derivative (ICT2588, see Cancer Research, 2010, 70, 6902-6912), which is now licensed to University of Bradford spin-out company Incanthera Ltd (www.incanthera.com) and received global press coverage at the British Science Festival 2011 (e.g ... green cscs card test